CSPC Pharmaceutical Group Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 31,450.11 million compared to CNY 30,936.9 million a year ago. Net income was CNY 5,873.33 million compared to CNY 6,091.39 million a year ago.

Basic earnings per share from continuing operations was CNY 0.4947 compared to CNY 0.5111 a year ago. Diluted earnings per share from continuing operations was CNY 0.4947 compared to CNY 0.5111 a year ago.